Proctor and Gamble 2005 Annual Report Download - page 20
Download and view the complete annual report
Please find page 20 of the 2005 Proctor and Gamble annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.Net Sales
(in billions of dollars)
2004 20052003
15.7
17.7
19.7
2.3
Net Earnings
(in billions of dollars)
2004 20052003
1.9
1.6
FiscalYear2005Results
P&GFamilyHealthdeliveredastrongyearofvolume,sales,
andprofitgrowth.Unitvolumegrew8%,netsalesgrew
11%,andnetearningsincreased18%.Thegrowthhasbeen
broad-basedacrosstheportfolioofleadingbrands.Sixof
P&G’s17billion-dollarbrandsareinFamilyHealth–Pampers,
Crest,Bounty,Charmin,Iams,andActonel–andVicksand
PrilosecOTCareinthenexttierofbrandswithannualsales
between$500millionand$1billion.Alleightofthesebrands
deliveredsolidglobalvolumegrowthinfiscalyear2005.
BabyCareandFamilyCareledthewaywithcombined
salesup11%andprofitsup28%.BabyCarecontinued
toextenditsgloballeadershipwithglobalmarketshareof
37%behindsoundproductinitiatives,holisticmarketing,
andexpandedproductofferingstolower-incomeconsumers.
PampersalsolaunchedKandoochildren’spersonalcare
productsinNorthAmericaandexpandedthelineupin
WesternEurope,furtherextendingthefranchisefrombabies
toyoungerchildren.FamilyCaremadestrongprogress
behinditsBounty,Charmin,Puffs,andTempobrandsinall
regionswhereweoperate.InthecoremarketoftheU.S.,
FamilyCaremarketsharerosetoover30%.Inaddition,
BabyCareandFamilyCarehavesuccessfullyexecutedprice
increasestooffsethighercommoditycosts,whichalso
helpedyear-on-yearprofitgrowth.
InHealthCare,saleswereup11%andprofitsup8%.
PharmaceuticalsandPersonalHealthCareledthewaywith
excellentgrowthonActonelandPrilosecOTC.Actonel
hasnowachieveda33%globalshareofbisphosphonates
inthefast-growingosteoporosismarket.PrilosecOTC
achievedaU.S.shareof35%.OralCaredeliveredmodest
volumegrowth,despiteaggressivecompetitiveactivityand
contractionofthetooth-whiteningmarket,basedonstrong
performanceinChinaandRussiaontheCrestandBlend-
a-Medbrands.IntheU.S.,Crestextendeditsfranchise
intooralrinseswiththelaunchofCrestPro-HealthRinse,
ano-alcoholformulathatkillsgermsthatcauseplaque
andgingivitiswithouttheburnofalcohol.PetHealth&
Nutritionpostedsolidtop-lineresults,ledbygrowthin
NorthAmericaandJapan.Iamsisnowthesinglelargestpet
carebrandintheU.S.
What’sWorking
Wehavesharpenedourfocusonkeepingfamilieshealthy
forlife.Wedothisbydelightingconsumerswithbetter
performingproductsthatrepresentgoodvalueforthe
16
Top10P&GFamilyHealthBrands(NetSales)
Charmin
posted8%
volume
growth
behind
product
innovations
suchas
MegaRoll.
Cresttoothpasteshare
inChinaincreased>8%
pointstoover25%.
PrilosecOTC
marketsharereached
35%
oftheU.S.heartburn
treatmentsegment.
P&GFamilyHealth